课题基金 / 基金详情

NORTHEASTERN COOPERATIVE MULTIPLE SCLEROSIS TREATMENT GROUP II

NORTHEASTERN COOPERATIVE MULTIPLE SCLEROSIS TREATMENT GROUP II
东北多发性硬化症合作治疗组 II
批准号：
3907510
负责人：
HOWARD L WEINER
金额：
$0.0万
依托单位：
BRIGHAM AND WOMEN'S HOSPITAL
依托单位国家：
美国
项目类别：
财政年份：
--
资助国家：
美国
项目状态：
未结题
起止时间：
至
来源：
https://reporter.nih.gov/project-details/3907510
关键词：
adrenocorticotropic hormone combination chemotherapy cyclophosphamide human subject human therapy evaluation methylprednisolone multiple sclerosis nervous system disorder chemotherapy

项目摘要

项目成果

HOWARD L WEINER的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The purpose of this protocol is to determine whether induction using IV methylprednisolone is as efficacious in progressive multiple sclerosis as using cyclophosphamide ACTH. In addition, it tests whether maintenance therapy using monthly boosters of cyclophosphamide plus methylprednisolone are efficacious as compared to monthly boosters of methylprednisolone alone.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Hedgehog, Patched, and Gli in Medulloblastoma
Hedgehog, Patched, and Gli in Medulloblastoma
Hedgehog, Patched, and Gli in Medulloblastoma
Hedgehog, Patched, and Gli in Medulloblastoma
海外基金